✦ LIBER ✦

An Open-Label, Single-Dose, Parallel-Group Study of the Effects of Chronic Hepatic Impairment on the Safety and Pharmacokinetics of Desvenlafaxine

✍ Scribed by Baird-Bellaire, Susan; Behrle, Jessica A.; Parker, Vernon D.; Patat, Alain; Paul, Jeffrey; Nichols, Alice I.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of hepatic impairment on the pha

✍ Ophelia Q.P. Yin; Neil Gallagher; Chiaki Tanaka; Deirdre Fisher; Venkat Sethuram 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Influence of Hepatic Impairment on the P

✍ Sreeneeranj Kasichayanula; Xiaoni Liu; Weijiang Zhang; Marc Pfister; Frank P. La 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 813 KB

Effects of Hepatic Impairment on the Pha

✍ Peveling-Oberhag, Jan; Zeuzem, Stefan; Yong, Wei Peng; Kunz, Tiffany; Paquet, Th 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 994 KB

Effects of hepatic impairment on the ste

✍ Monika Schöller-Gyüre; Thomas N. Kakuda; Goedele De Smedt; Brian Woodfall; Cindy 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 851 KB

An open-label study to estimate the effe

✍ Moore, Kenneth T.; Vaidyanathan, Seema; Natarajan, Jaya; Ariyawansa, Jay; Haskel 📂 Article 📅 2014 🏛 Sage Publications 🌐 English ⚖ 473 KB

An Open-Label, Parallel Group Study Inve

✍ Damholt, B. 📂 Article 📅 2006 🏛 Sage Publications 🌐 English ⚖ 125 KB